Sleep Disorders Trial, Recruiting NCT02824822 Sponsor: Mayo Clinic Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT02824822
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 50 years old who have been diagnosed with epilepsy, seizures, fainting, drowning, cardiac arrest, sudden death, or who have had an abnormal heart test (ECG) suggesting an irregular heartbeat
  • Blood relatives (aged 18 or older) of someone who has a history of epilepsy, seizures, cardiac arrest, sudden death, drowning, fainting, or an irregular heartbeat

Who may not be able to join:

  • People who are unable to sign a written consent form
  • People who are currently in prison
  • People whose seizures were caused by a stroke or lack of blood flow to the brain
  • People who had seizures caused by a brain injury from an accident or physical trauma
  • People who have previously had surgery on their brain
  • People who have a history of a brain tumour

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 May 2016
Est. completion
1 December 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Using Next Generation Whole-Exome Sequencing, determine if an underlying genetic cardiac mutation is present in refractory epilepsy patients who are at highest risk of sudden death.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov